Back to search

Article

Metabolic Switch in Endocrine Resistant Estrogen Receptor Positive Breast Cancer

2024-12-29

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Purpose</h4> The development of endocrine resistance remains a significant challenge in the clinical management of estrogen receptor-positive ( ER+ ) breast cancer. Metabolic reprogramming is a prominent component of endocrine resistance and a potential therapeutic intervention point. However, a limited understanding of which metabolic changes are conserved across the heterogeneous landsca...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2ad3b805-e396-527f-b70a-4a6cf6e189f7
DOI
10.1101/2024.12.28.630631
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Metabolic Switch in Endocrine Resistant Estrogen Receptor Positive Breast CancerDOI 10.1101/2024.12.28.630631
ACSS2-Mediated Metabolic-Epigenetic Crosstalk Drives Fulvestrant Resistance and Represents a Novel Therapeutic TargetSemantic proximity
Unraveling Vulnerabilities in Endocrine Therapy-Resistant HER2+/ER+ Breast CancerSemantic proximity
Adenosine triphosphate citrate lyase alters cellular myelocytomatosis oncogene signaling and fatty acid oxidation in residual breast cancer tumor tissues after neoadjuvant treatmentSemantic proximity
Lipid metabolic reprogramming drives triglyceride storage and variable sensitivity to FASN inhibition in endocrine-resistant breast cancer cellsSemantic proximity
Palbociclib and fulvestrant act in synergy to modulate central carbon metabolism in breast cancer cellsSemantic proximity
Omics Analysis of Chemoresistant Triple Negative Breast Cancer Cells Reveals Novel Metabolic VulnerabilitiesSemantic proximity
Metabolic Reprogramming: A Friend or Foe to Cancer Therapy?Semantic proximity
Lipid Metabolism Reprogramming and Trastuzumab Resistance in Breast Cancer Cell Lines Overexpressing the ERBB2 Membrane ReceptorSemantic proximity
Integrated Genomic Profiling Reveals Mechanisms of Broad Drug Resistance and Opportunities for Phenotypic Reprogramming in Cancer CellsSemantic proximity
Association of tamoxifen resistance and lipid reprogramming in breast cancerSemantic proximity
Oncogenic role of fumarate hydratase in breast cancer: metabolic reprogramming and mechanistic insightsSemantic proximity
Identifying personalized metabolic signatures in breast cancerSemantic proximity
Select a neighboring publication to make it the new centre.